SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-16-118269
Filing Date
2016-05-05
Accepted
2016-05-05 16:03:19
Documents
52
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a16-6532_110q.htm 10-Q 798641
2 EX-31.1 a16-6532_1ex31d1.htm EX-31.1 11282
3 EX-31.2 a16-6532_1ex31d2.htm EX-31.2 11801
4 EX-32 a16-6532_1ex32.htm EX-32 9755
  Complete submission text file 0001104659-16-118269.txt   4281759

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT inva-20160331.xml EX-101.INS 968963
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT inva-20160331.xsd EX-101.SCH 41730
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT inva-20160331_cal.xml EX-101.CAL 48584
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT inva-20160331_def.xml EX-101.DEF 129764
9 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT inva-20160331_lab.xml EX-101.LAB 359909
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT inva-20160331_pre.xml EX-101.PRE 244544
Mailing Address 951 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080
Business Address 951 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 6502389600
Innoviva, Inc. (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30319 | Film No.: 161623595
SIC: 2834 Pharmaceutical Preparations